Vaso (VASO) Gross-Profit-to-Asset % : 64.41% (As of Sep. 2024)

View and export this data going back to 2006. Start your Free Trial

What is Vaso Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Vaso's annualized Gross Profit for the quarter that ended in Sep. 2024 was $47.02 Mil. Vaso's average Total Assets over the quarter that ended in Sep. 2024 was $73.00 Mil. Therefore, Vaso's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2024 was 64.41%.

Vaso Gross-Profit-to-Asset % Historical Data

The historical data trend for Vaso's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vaso Gross-Profit-to-Asset % Chart

Vaso Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

80.95

73.65

83.97

77.26

68.65

Vaso Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Gross-Profit-to-Asset %	Get a 7-Day Free Trial															65.71	75.56	60.15	68.69	64.41

Competitive Comparison of Vaso's Gross-Profit-to-Asset %

For the Health Information Services subindustry, Vaso's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vaso's Gross-Profit-to-Asset % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Vaso's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Vaso's Gross-Profit-to-Asset % falls into.

Vaso Gross-Profit-to-Asset % Calculation

Vaso's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2023 )	/	( (Total Assets (A: Dec. 2022 )	+	Total Assets (A: Dec. 2023 ))	/ count )
	=	50.593	/	( (71.645	+	75.757)	/ 2 )
	=	50.593	/	73.701
	=	68.65 %

Vaso's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2024 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Sep. 2024 )	/	( (Total Assets (Q: Jun. 2024 )	+	Total Assets (Q: Sep. 2024 ))	/ count )
	=	47.024	/	( (72.063	+	73.943)	/ 2 )
	=	47.024	/	73.003
	=	64.41 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Sep. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Vaso Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Vaso's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Vaso Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Vaso Corp (OTCPK:VASO) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

N/A

Address

137 Commercial Street, Unit 200, Plainview, NY, USA, 11803

Website

https://www.vasocorporation.com

Vaso Corp is a medical technology company. It provides diverse product and service categories, including noninvasive monitoring and therapeutic devices, diagnostic imaging equipment, and information technology for enterprises and clinical customers. The company currently operates in three distinct business units namely IT; Professional sales and Equipment. It generates maximum revenue from the IT segment. IT segment focuses on healthcare IT and managed network technology services.

Executives

Jun Ma	director	C/O VASOMEDICAL, INC., 180 LINDEN AVENUE, WESTBURY NY 11590
Leon Dembo	director	137 COMMERCIAL STREET, SUITE 200, PLAINVIEW NY 11803
Janey Moen	director	137 COMMERCIAL STREET, SUITE 200, PLAINVIEW NY 11803
Edgar Rios	director	1650 TYSONS BOULEVARD, SUITE 900, MCLEAN VA 22102
Michael Beecher	officer: Chief Financial Officer	C/O DIRECT INSITE CORP, 80 ORVILLE DRIVE, BOHEMIA NY 11716
Joshua Markowitz	director	3131 PRINCETON PIKE, BLDG. 3D, SUITE 200, LAWRENCEVILLE NJ 08648
Jonathan P Newton	officer: Vice Pres Finance & Controller	152 RICHMOND AVENUE, AMITYVILLE NY 11701
Peter C Castle	director	C/O NETWOLVES CORP, 4002 EISENHOWER BLVD, TEMPA FL 33634
David H Lieberman	director	3061 INDUSTRY DR, LANCASTER PA 17603
Behnam Movaseghi	director	C/O KERNS MANUFACTURING CORPORATION, 37-14 29TH STREET, LONG ISLAND CITY NY 11101
Nelson Randall Hill	officer: Senior Vice President	3880 EAST COUNTY HIGHWAY 30A, UNIT 201, SANTA ROSA BEACH FL 24159
William Edward Dempsey	director	52 PARK AVENUE, SANDYMOUNT L2 DUBLIN 4
David Tarachand Singh	officer: Chief Financial Officer	C/O VASOMEDICAL, INC., 180 LINDEN AVENUE, WESTBURY NY 11590
Joseph Giacalone	director
Derek Enlander	director	88C UNION AVENUE, CENTER MORICHES NY 11934